Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?
Abstract
Background
Vitamin D deficiency is associated with significant increases in the incidence of cardiovascular risk factors and mortality. However, the mechanisms underlying this association remain unclear. The current study evaluated the possible relationships among vitamin D status, endothelial dysfunction, and inflammation.
Methods
Plasma concentrations of 25-hydroxyvitamin D3 were determined by radioimmunoassay in a normal population cohort (n
=
253) aged 51 to 77 years (mean 63.4
±
6 years). Asymmetric dimethylarginine, a marker/mediator of endothelial dysfunction, was assayed by high-performance liquid chromatography. High-sensitivity C-reactive protein levels were used as a marker of inflammatory activation.
Results
On univariate analyses, low 25-hydroxyvitamin D3 levels were inversely correlated with asymmetric dimethylarginine concentrations, high-sensitivity C-reactive protein levels, and body mass index. Seasonal fluctuations in 25-hydroxyvitamin D3 levels were associated with reciprocal asymmetric dimethylarginine concentration fluctuations. Hypertension and treatment with an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker also were associated with low 25-hydroxyvitamin D3 levels. On multiple linear analysis, both asymmetric dimethylarginine (β
=
−0.19, P
=
.003) and high-sensitivity C-reactive protein (β
=
−0.14, P
=
.03) concentrations were inversely correlated with plasma 25-hydroxyvitamin D3 concentrations; other significant correlates were male gender (β
=
0.19, P
=
.003), calcium levels (β
=
0.14, P
=
.03), and use of angiotensin-converting enzyme inhibitor (β
=
−0.17, P
=
.007).
Conclusion
Low 25-hydroxyvitamin D3 levels are associated with markers of endothelial dysfunction and inflammatory activation, representing potential mechanisms for incremental coronary risk.
Keywords: Asymmetric dimethylarginine, Cardiovascular risk, Endothelial dysfunction, High-sensitivity C-reactive protein, Vitamin D
To access this article, please choose from the options below
Funding: This work was supported in part by research grants from the National Health and Medical Research Council and National Heart Foundation of Australia.
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(09)01014-6
doi:10.1016/j.amjmed.2009.09.024
© 2010 Elsevier Inc. All rights reserved.

